Literature DB >> 1851058

Identification of a myeloperoxidase inhibitor from normal human serum.

C M Yea1, B Dularay, C J Elson.   

Abstract

An inhibitor of myeloperoxidase (MPO) has been identified in normal human serum. Initial experiments confirmed that high levels of MPO inhibitory activity are present in sera and that the inhibitor did not act by interfering with the assay. Purification of the inhibitor activity by salt precipitation followed by ion exchange and affinity chromatography revealed the presence of a protein of 150 kD. The purified inhibitory activity displayed dose and time dependency and was not associated with IgG or IgA. It is considered that human serum contains an inhibitor of extracellular MPO capable of protecting against hypohalous acid release in host tissues and that if inhibitor levels are reduced such protection may fail.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1851058      PMCID: PMC1535409          DOI: 10.1111/j.1365-2249.1991.tb08171.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  16 in total

1.  Lysosomal enzymes in inflammatory synovial effusions.

Authors:  N M Hadler; J K Spitznagel; R J Quinet
Journal:  J Immunol       Date:  1979-08       Impact factor: 5.422

2.  Oxygen-dependent microbial killing by phagocytes (first of two parts).

Authors:  B M Babior
Journal:  N Engl J Med       Date:  1978-03-23       Impact factor: 91.245

3.  The superoxide-generating NADPH oxidase of human neutrophils is electrogenic and associated with an H+ channel.

Authors:  L M Henderson; J B Chappell; O T Jones
Journal:  Biochem J       Date:  1987-09-01       Impact factor: 3.857

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  The neutrophil.

Authors:  M Baggiolini; B Dewald
Journal:  Int Arch Allergy Appl Immunol       Date:  1985

6.  Release of lysosomal enzymes from human polymorphonuclear leukocytes by soluble intermediate immune complexes.

Authors:  A D Morrison; W Pruzanski; N S Ranadive
Journal:  Scand J Rheumatol       Date:  1978       Impact factor: 3.641

7.  Protein A reactivity of various mammalian immunoglobulins.

Authors:  J Goudswaard; J A van der Donk; A Noordzij; R H van Dam; J P Vaerman
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

8.  Recombinant human interleukin-1 beta primes human polymorphonuclear leukocytes for stimulus-induced myeloperoxidase release.

Authors:  B Dularay; C J Elson; S Clements-Jewery; C Damais; D Lando
Journal:  J Leukoc Biol       Date:  1990-02       Impact factor: 4.962

9.  Depressed degranulation response of synovial fluid polymorphonuclear leucocytes from patients with rheumatoid arthritis to IgG aggregates.

Authors:  B Dularay; P A Dieppe; C J Elson
Journal:  Clin Exp Immunol       Date:  1990-02       Impact factor: 4.330

10.  Assay method for myeloperoxidase in human polymorphonuclear leukocytes.

Authors:  K Suzuki; H Ota; S Sasagawa; T Sakatani; T Fujikura
Journal:  Anal Biochem       Date:  1983-07-15       Impact factor: 3.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.